+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Pharmaceutical Continuous Manufacturing Market Research Report by Distribution, Application, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 256 Pages
  • July 2022
  • Region: Global
  • 360iResearch™
  • ID: 4968719
UP TO OFF until Dec 31st 2022
The Global Pharmaceutical Continuous Manufacturing Market size was estimated at USD 527.32 million in 2021, USD 594.13 million in 2022, and is projected to grow at a CAGR 12.63% to reach USD 1,076.65 million by 2027.

Market Statistics:


The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Pharmaceutical Continuous Manufacturing to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Distribution, the market was studied across Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy.
  • Based on Application, the market was studied across Active Pharmaceutical Ingredient, Biologics, and Dry Powders.
  • Based on End User, the market was studied across Contract Manufacturing Organization and Pharmaceutical Companies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Pharmaceutical Continuous Manufacturing market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Pharmaceutical Continuous Manufacturing Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Pharmaceutical Continuous Manufacturing Market, including 3P Biopharmaceuticals, Abbott, AbbVie Inc., ABN Cleanroom Technology, AC Immune, Baker Perkins Ltd, Bayer AG, Bosch Packaging Technology, Chemtrix, Continuous Pharmaceutical, Coperion GmbH, Corning Life Sciences, Eli Lilly and Company, GEA, Gebrüder Lödige Maschinenbau GmbH, Genzyme Corporation, Glatt GmbH, Hosokawa Micron Corporation, Janssen Global Services, LLC, Johnson & Johnson’s,, Korsch AG, L.B. Bohle Maschinen + Verfahren GmbH, Novartis AG, S K Biotek Ltd, Scott Equipment Company, Siemens AG, Sturtevant, Inc, Syntegon Technology GmbH, and Thermo Fisher Scientific Inc..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Pharmaceutical Continuous Manufacturing Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Pharmaceutical Continuous Manufacturing Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Pharmaceutical Continuous Manufacturing Market?
4. What is the competitive strategic window for opportunities in the Global Pharmaceutical Continuous Manufacturing Market?
5. What are the technology trends and regulatory frameworks in the Global Pharmaceutical Continuous Manufacturing Market?
6. What is the market share of the leading vendors in the Global Pharmaceutical Continuous Manufacturing Market?
7. What modes and strategic moves are considered suitable for entering the Global Pharmaceutical Continuous Manufacturing Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Potential Demand Attributed to Cost-Effective Approach
5.1.1.2. Favorable Regulatory Policies for Adoption of Continuous Manufacturing Systems
5.1.1.3. Increasing Application Owing to Better Efficiency of Manufacturing Operations
5.1.2. Restraints
5.1.2.1. Dearth of Technical and Regulatory Clarities
5.1.3. Opportunities
5.1.3.1. Emerging Collaborations Between Industry and Academics
5.1.3.2. Ongoing Growth in Generic Manufacturing
5.1.4. Challenges
5.1.4.1. High Infrastructural Investments and Concerns Regarding Cleaning Validation
5.2. Cumulative Impact of COVID-19
6. Pharmaceutical Continuous Manufacturing Market, by Distribution
6.1. Introduction
6.2. Hospital Pharmacy
6.3. Online Pharmacy
6.4. Retail Pharmacy
7. Pharmaceutical Continuous Manufacturing Market, by Application
7.1. Introduction
7.2. Active Pharmaceutical Ingredient
7.3. Biologics
7.4. Dry Powders
8. Pharmaceutical Continuous Manufacturing Market, by End-user
8.1. Introduction
8.2. Contract Manufacturing Organization
8.3. Pharmaceutical Companies
9. Americas Pharmaceutical Continuous Manufacturing Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Pharmaceutical Continuous Manufacturing Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
11. Europe, Middle East & Africa Pharmaceutical Continuous Manufacturing Market
11.1. Introduction
11.2. France
11.3. Germany
11.4. Italy
11.5. Netherlands
11.6. Qatar
11.7. Russia
11.8. Saudi Arabia
11.9. South Africa
11.10. Spain
11.11. United Arab Emirates
11.12. United Kingdom
12. Competitive Landscape
12.1. Fpnv Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis
12.3. Market Share Analysis, by Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. 3P Biopharmaceuticals
13.2. Abbott
13.3. Abbvie Inc.
13.4. Abn Cleanroom Technology
13.5. Ac Immune
13.6. Baker Perkins Ltd
13.7. Bayer Ag
13.8. Bosch Packaging Technology
13.9. Chemtrix
13.10. Continuous Pharmaceutical
13.11. Coperion GmbH
13.12. Corning Life Sciences
13.13. Eli Lilly and Company
13.14. Gea
13.15. Gebrüder Lödige Maschinenbau GmbH
13.16. Genzyme Corporation
13.17. Glatt GmbH
13.18. Hosokawa Micron Corporation
13.19. Janssen Global Services, LLC
13.20. Johnson & Johnson's,
13.21. Korsch Ag
13.22. L.B. Bohle Maschinen + Verfahren GmbH
13.23. Novartis Ag
13.24. S K Biotek Ltd
13.25. Scott Equipment Company
13.26. Siemens Ag
13.27. Sturtevant, Inc
13.28. Syntegon Technology GmbH
13.29. Thermo Fisher Scientific Inc.
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2021 VS 2027 (USD MILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2021 VS 2027 (%)
FIGURE 5. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2027
FIGURE 7. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET DYNAMICS
FIGURE 8. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (%)
FIGURE 9. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2021 VS 2027 (USD MILLION)
FIGURE 10. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2027
FIGURE 11. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, 2019-2027 (USD MILLION)
FIGURE 12. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, 2019-2027 (USD MILLION)
FIGURE 14. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, 2019-2027 (USD MILLION)
FIGURE 16. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 18. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2027
FIGURE 20. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, 2019-2027 (USD MILLION)
FIGURE 21. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, 2019-2027 (USD MILLION)
FIGURE 23. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, 2019-2027 (USD MILLION)
FIGURE 25. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2021 VS 2027 (%)
FIGURE 27. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2021 VS 2027 (USD MILLION)
FIGURE 28. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2027
FIGURE 29. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 35. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 36. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2027
FIGURE 37. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 43. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 44. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY STATE, 2027
FIGURE 45. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 47. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 48. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2027
FIGURE 49. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (%)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2021 VS 2027 (USD MILLION)
FIGURE 63. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2027
FIGURE 64. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 75. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 76. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 77. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 7. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 9. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 10. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 12. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 14. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 15. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2019-2027 (USD MILLION)
TABLE 17. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 18. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY STATE, 2019-2027 (USD MILLION)
TABLE 19. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY REGION, 2019-2027 (USD MILLION)
TABLE 23. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY STATE, 2019-2027 (USD MILLION)
TABLE 25. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 26. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY ACTIVE PHARMACEUTICAL INGREDIENT, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY REGION, 2019-2027 (USD MILLION)
TABLE 28. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY STATE, 2019-2027 (USD MILLION)
TABLE 30. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY REGION, 2019-2027 (USD MILLION)
TABLE 33. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY STATE, 2019-2027 (USD MILLION)
TABLE 35. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DRY POWDERS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 39. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 41. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 42. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 44. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 46. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 47. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 51. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 53. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 55. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 56. ARGENTINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 57. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 58. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 59. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 60. BRAZIL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 61. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 62. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 63. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 64. CANADA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 65. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 66. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 67. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 68. MEXICO PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 70. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY STATE, 2019-2027 (USD MILLION)
TABLE 71. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 72. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 73. UNITED STATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 75. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 77. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 78. ASIA-PACIFIC PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 79. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 80. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 81. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 82. AUSTRALIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 83. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 85. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 86. CHINA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 87. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 89. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 90. INDIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 91. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 93. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 94. INDONESIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 95. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 97. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 98. JAPAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 99. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 101. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 102. MALAYSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 103. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 105. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 106. PHILIPPINES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 107. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 108. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 109. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 110. SINGAPORE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 111. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 112. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 113. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 114. SOUTH KOREA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 115. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 116. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 117. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 118. TAIWAN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 119. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 120. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 121. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 122. THAILAND PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 128. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 129. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 130. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 131. FRANCE PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 132. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 133. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 134. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 135. GERMANY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 136. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 137. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 138. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 139. ITALY PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 140. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 141. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 142. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 143. NETHERLANDS PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 144. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 145. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 146. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 147. QATAR PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 148. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 149. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 150. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 151. RUSSIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 152. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 153. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 154. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 155. SAUDI ARABIA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 156. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 157. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 158. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 159. SOUTH AFRICA PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 160. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 161. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 162. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 163. SPAIN PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 168. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 169. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY DISTRIBUTION, 2019-2027 (USD MILLION)
TABLE 170. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 171. UNITED KINGDOM PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SIZE, BY END USER, 2019-2027 (USD MILLION)
TABLE 172. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 173. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 174. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 175. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET RANKING
TABLE 176. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2021
TABLE 177. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET MERGER & ACQUISITION
TABLE 178. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 179. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 180. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET INVESTMENT & FUNDING
TABLE 181. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 182. GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET: LICENSE & PRICING

Companies Mentioned

  • 3P Biopharmaceuticals
  • Abbott
  • AbbVie Inc.
  • ABN Cleanroom Technology
  • AC Immune
  • Baker Perkins Ltd
  • Bayer AG
  • Bosch Packaging Technology
  • Chemtrix
  • Continuous Pharmaceutical
  • Coperion GmbH
  • Corning Life Sciences
  • Eli Lilly and Company
  • GEA
  • Gebrüder Lödige Maschinenbau GmbH
  • Genzyme Corporation
  • Glatt GmbH
  • Hosokawa Micron Corporation
  • Janssen Global Services, LLC
  • Johnson & Johnson’s,
  • Korsch AG
  • L.B. Bohle Maschinen + Verfahren GmbH
  • Novartis AG
  • S K Biotek Ltd
  • Scott Equipment Company
  • Siemens AG
  • Sturtevant, Inc
  • Syntegon Technology GmbH
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...